diabetes mellitus | Research | 10 pages | source: Archives of Gynecology and Obstetrics | Added May 04, 2021
Can supplements improve the risk of gestational diabetes?
This review looked at whether dietary supplements can prevent gestational diabetes. It found that some supplements, including vitamin D and myo-inositol, could reduce diabetes for pregnant women.
diabetes mellitus | Research | 10 pages | source: Scientific reports | Added May 02, 2021
Are steroid eye implants effective for treating diabetic macular edema in real life?
This study looked at the real-life use of fluocinolone acetonide (Iluvien) inserts for the treatment of diabetic macular edema (DME). They found that this treatment results in a significant increase in vision over three years.
diabetes mellitus | Research | Treatment | 10 pages | source: Journal of Diabetes and its Complications | Added Apr 30, 2021
Which type of insulin is best for avoiding hypoglycemia in patients with high risk type 2 diabetes?
This study compared the risk of hypoglycemia (dangerously low blood glucose levels) for insulin glargine 300 U/ml (Gla-300; Toujeo) and standard-of-care basal insulin (SOC-BI) at patients with type 2 diabetes (T2D) with risk factors for hypoglycemia. It found that Gla-300 was associated with a lower risk of hypoglycemia than SOC-BI.
diabetes mellitus | Research | Treatment | 10 pages | source: Pharmacological research | Added Apr 25, 2021
Is dapagliflozin an effective treatment for type 1 diabetes?
This study looked at the use of dapagliflozin (Forxiga) in the treatment of type 1 diabetes (T1D). It found that compared to placebo, dapagliflozin resulted in a better blood glucose control, a reduction in body weight, and a reduced insulin dose.
diabetes mellitus | Research | 10 pages | source: Scientific reports | Added Apr 18, 2021
What is the best treatment regimen for diabetic macular edema?
This study looked at a treat-and-extend regimen of eye injections with aflibercept (Eylea) for the treatment of diabetic macular edema (DME). It found this regimen improved patients' vision.
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes, Obesity and Metabolism | Added Apr 13, 2021
Can using ultra-rapid lispro in patients with type 1 diabetes using subcutaneous insulin infusion improve glucose control after meals?
This study compared the effectiveness and safety of ultra-rapid lispro (URLi; LyumjevTM) to lispro (Humalog) in patients with type 1 diabetes (T1D) on continuous subcutaneous insulin infusion (CSII). The authors concluded that URLi was similarly effective and provided improved postprandial glucose (PPG) control with reduced hypoglycemia in these patients.
diabetes mellitus | Research | 10 pages | source: Nutrients | Added Apr 11, 2021
Can Vitamin B12 improve nerve function in patients with diabetes and nerve dysfunction?
This study looked at the effectiveness of vitamin B12 in people with type 2 diabetes (T2D) and loss of nerve function. It found that the vitamin improved pain, sensation, and quality of life in these patients.
rheumatoid arthritis | Research | Treatment | 10 pages | source: Annals of the rheumatic diseases | Added Apr 10, 2021
Can low disease activity be achieved with a modern treatment approach in pregnant women with rheumatoid arthritis?
This study evaluated whether a modern treatment approach is suitable in patients with rheumatoid arthritis (RA) that were pregnant or intended to become pregnant. The authors concluded that low disease activity (LDA) and remission are possible with a modern approach in these women.
rheumatoid arthritis | Research | Lifestyle | 10 pages | source: Rheumatology International | Added Apr 04, 2021
Does smoking impact seropositivity levels in patients with rheumatoid arthritis?
This study assessed the link between smoking and seropositivity levels of specific autoantibodies in patients with rheumatoid arthritis (RA). The authors concluded that patients with RA who were current smokers had significantly higher seropositivity levels than those that never smoked.
diabetes mellitus | Research | Treatment | 10 pages | source: The lancet. Diabetes & endocrinology | Added Mar 30, 2021
Does empagliflozin reduce the risk of heart attack, stroke and death in patients with type 2 diabetes and heart disease?
This study looked at the risk of heart attack, stroke, and death in patients with type 2 diabetes (T2D) and heart disease treated with empagliflozin (Jardiance). They found that empagliflozin reduced the total risk of heart attack, stroke, or death in these patients.